Functional Connectivity and Predictors of Affective Aprosodia Intervention in Subacute Right Hemisphere Stroke
NCT ID: NCT04575909
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-02-01
2024-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Studying Language With Brain Stimulation in Aphasia
NCT05660304
Treating Intention In Aphasia: Neuroplastic Substrates
NCT00567242
Strategy Training for People With Aphasia After Stroke
NCT03593876
Clinical Study on the Safety and Efficacy of Temporal Interference Stimulation in the Treatment of Post-Stroke Aphasia
NCT07346378
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
NCT02094014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Following damage to the right side of the brain, such as in stroke, difficulties in affective prosody understanding and use have been observed. These findings have led researchers to view the right hemisphere as playing a critical role for emotional prosody. Affective prosody difficulties do not always spontaneously improve after acute right hemisphere stroke, and only a few evidenced-based treatments are available for these individuals. It is also understood that affective prosody difficulties can negatively impact social interactions and relationships, including those who care for individuals with emotional prosody difficulties. With miscommunication frequently occurring between those living with affective prosody disorders and those with whom these people interact, the risk of reduced quality of life and social isolation is possible and could be related to poorer health outcomes. Not only might there be personal burdens associated with poor management of communication difficulties in right hemisphere stroke and dementia, but there might also be economic burdens as well. In addition to counseling caregivers, family, and friends about the communication changes of loved ones, more evidenced-based speech and language treatment options are needed for those living with affective prosody disorders.
Cognitive-Linguistic and Speech-Language Assessment: During baseline testing, detailed speech-language and cognitive-communication behavioral testing will occur, focusing on aprosodia, awareness, motor speech, attention, verbal working memory, executive function, discourse, social participation, and emotion. Detailed testing focusing on aprosodia will occur after each Intervention Phase.
Functional near-infrared spectroscopy: Resting state functional connectivity as measured via functional near-infrared spectroscopy (fNIRS) will be assessed at Baseline, Post Phase I, and Post Phase II testing time points to track longitudinal change in functional connectivity patterns associated with targeted aprosodia intervention.
Aprosodia Intervention Phase: The aprosodia intervention will target receptive and expressive prosody over the course of four (4) weeks (12 sessions total). The receptive prosody intervention phase will occur for two weeks (6 sessions total, 3 sessions/week), and the expressive prosody intervention phase will occur for two weeks (6 sessions total, 3 sessions/week). Within each phase, the types of cues participants receive will also vary. Half of the expressive prosody intervention phase will use explicit cues (3 sessions total, 1 week), and the other half of the expressive prosody intervention phase will use implicit cues (3 sessions total, 1 week). This same setup for expressive prosody intervention phase will be used in the receptive prosody intervention phase. In addition to these implicit and explicit cues, expressive prosody intervention will also include feedback to increase awareness.
No-Intervention Phase: Participants will meet study personnel with the same frequency and duration (3 sessions/week, \~1 hour/session) during the No-Intervention Phase as during REACT. Sessions will comprise conversation about current events, recovery progress (including speech therapy goals targeted in outside intervention \[if relevant\]), hobbies, and other similar topics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Explicit Expressive Prosody Intervention
Explicit cues will be provided to help participants improve expression of targeted affective prosody.
Aprosodia Intervention
Intervention will focus on improving participants' use and understanding of emotional prosody using implicit and explicit cues, biofeedback, modeling, and feedback.
Implicit Expressive Prosody Intervention
Implicit cues will be provided to help participants improve expression of targeted affective prosody.
Aprosodia Intervention
Intervention will focus on improving participants' use and understanding of emotional prosody using implicit and explicit cues, biofeedback, modeling, and feedback.
Explicit Receptive Prosody Intervention
Explicit cues will be provided to help participants improve recognition of targeted affective prosody.
Aprosodia Intervention
Intervention will focus on improving participants' use and understanding of emotional prosody using implicit and explicit cues, biofeedback, modeling, and feedback.
Implicit Receptive Prosody Intervention
Implicit cues will be provided to help participants improve recognition of targeted affective prosody.
Aprosodia Intervention
Intervention will focus on improving participants' use and understanding of emotional prosody using implicit and explicit cues, biofeedback, modeling, and feedback.
No-Intervention
Sessions will comprise conversation about current events, recovery progress (including speech therapy goals targeted in outside intervention \[if relevant\]), hobbies, and other similar topics.
No-Intervention
Sessions will comprise conversation about current events, recovery progress (including speech therapy goals targeted in outside intervention \[if relevant\]), hobbies, and other similar topics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aprosodia Intervention
Intervention will focus on improving participants' use and understanding of emotional prosody using implicit and explicit cues, biofeedback, modeling, and feedback.
No-Intervention
Sessions will comprise conversation about current events, recovery progress (including speech therapy goals targeted in outside intervention \[if relevant\]), hobbies, and other similar topics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No history of other significant neurological disease or injury affecting the brain (excluding prior lacunar stroke, asymptomatic stroke, or TIA)
* Proficient speaker of English prior to stroke per self-report
* Capable of providing informed consent or indicating another to provide informed consent
* Ages 18-89
* Demonstration of receptive and/or expressive aprosodia on standardized measures of aprosodia
* Does not have severe cognitive impairment (MoCA \> 9)
* Is not severely depressed (PHQ-9 \< 20)
* Does not have more than mild motor speech impairment (ASRS \< 16 and Dysarthria severity \< 3)
* Normal or corrected-to-normal hearing and vision via screening tasks and self-report
* Medically stable
* Not taking any medications that may interfere with prosody processing
* Participation in speech therapy not targeting aprosodia
Exclusion Criteria
* History of symptomatic stroke or significant neurological disease or injury affecting the brain
* No proficiency in English based on self-report
* Unable to provide informed consent or to indicate another to provide informed consent
* Children \< 18 and adults 90+ years
* No demonstration of expressive or receptive aprosodia
* Severe cognitive-linguistic impairment (MoCA \< 16)
* Severe depression (PHQ-9 \> 19)
* More than mild motor speech impairment (ASRS \> 15 + Dysarthria severity \< 2)
* Uncorrected hearing/vision loss via screening tasks and self-report
* Not medically stable
* Reported medication use that may interfere with prosody processing
* Participating in outside speech therapy targeting aprosodia
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Argye E Hillis, MD, MA
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins School of Medicine
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00264439
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.